rethinkTHC Search
Menu
Study breakdown

Global Drug Use Disorder Burden: Fewer New Cases But More Deaths Over 30 Years

LongitudinalStrong evidence
The takeaway

Between 1990 and 2021, global drug use disorder incidence decreased 8% while mortality rose 31%, with 13.6 million new cases and 137,000 deaths in 2021 alone — opioids remained the deadliest.

Public health policymakers, addiction medicine professionals, epidemiologists, and global health researchers.

What the researchers found

In 2021: 13.6 million new drug use disorder cases, 137,278 deaths, 15.6 million DALYs. From 1990-2021: incidence decreased 8.1% but mortality rose 30.8% and DALYs rose 14.8%. Males and high-income regions disproportionately affected. Opioids dominated all metrics.

Why it matters

The paradox of declining incidence but rising mortality suggests treatment hasn't kept pace with the severity of drug use disorders. Cannabis use disorder, while less fatal than opioids, contributes significantly to the overall disability burden.

The numbers in context

2021: 13.6M new cases, 137,278 deaths, 15.6M DALYs. Opioid ASIR: 169.4/100K, ASMR: 1.7/100K. 1990-2021: ASIR -8.1%, ASMR +30.8%, DALY rate +14.8%.

How the study worked

Systematic analysis of the Global Burden of Disease Study 2021, calculating age-standardized incidence, mortality, and DALY rates for opioid, amphetamine, cocaine, and cannabis use disorders across sex, SDI, countries, and regions from 1990-2021.

What this study cannot tell us

GBD estimates rely on available data which varies dramatically by country. Cannabis use disorder diagnosis criteria and reporting have changed over time. Some regions have very limited data.

How to read the evidence

Comprehensive global analysis using the gold-standard GBD methodology, though dependent on variable data quality across countries.

When this study was published

The most comprehensive and current global analysis of drug use disorder trends available, covering three decades of data.

The bigger picture

This 30-year global analysis shows that drug use disorders are becoming more deadly even as fewer people develop them. Cannabis use disorder contributes to the disability burden, though opioids remain the primary driver of mortality.

Questions still open

  • Why is drug use disorder mortality rising while incidence declines? Is the increasing potency of substances — including cannabis — contributing to more severe cases?

Common questions

Is drug addiction getting worse globally?
It's complex — fewer new cases are developing (8% decline) but more people are dying (31% increase), suggesting the cases that do occur are more severe or less effectively treated.
Where does cannabis rank among drug use disorders?
Cannabis contributes to the overall disability burden but is far less fatal than opioids, which dominate mortality statistics. The main cannabis concern is disability (DALYs) rather than deaths.

Read the original research

Global burden of disease due to opioid, amphetamine, cocaine, and cannabis use disorders, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

PloS one, 20(8), e0328276

Citation

Zhu, David T; Kwon, Ye In Christopher; Lai, Alan; Park, Andrew Min-Gi; Barnes, Andrew J; Chapman, Derek A. (2025). Global burden of disease due to opioid, amphetamine, cocaine, and cannabis use disorders, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.. PloS one, 20(8), e0328276. https://doi.org/10.1371/journal.pone.0328276

Explore the wider topic